The Food and Drug Administration (FDA) issued a safety warning in April 2018 stating that Lamictal has been connected to a significant immunity system reaction called hemophagocytic lymphohistiocytosis (HLH).
The link has led the FDA to require that Lamictal maker GlaxoSmithKline provide a new warning that will be included with the medication's prescribing information and drug label.
HLH can be an immunodeficiency that is life-threatening, affecting those of all ages and ethnic groups. Symptoms of HLH include:
Fever Enlarged liver—symptoms may include pain, tenderness, or unusual swelling within the liver area in the upper right belly Swollen lymph nodes Skin rash Yellow skin or eyes Unusual bleeding Nervous system problems—including seizures, trouble walking, difficulty seeing, or other visual disturbances The FDA says that HLH can be confused with other drug reactions including Drug Reaction with Eosinophilia and Systemic Symptoms, or DRESS.
Those who have HLH will normally have at least five of the next symptoms:
Fever and rash Enlarged spleen Cytopenias Elevated levels of triglycerides or low blood levels of fibrinogen High quantities of blood ferritin Hemophagocytosis identified through bone marrow, spleen, or lymph node biopsy Decreased or absent Natural Killer (NK) Cell activity Elevated blood levels of CD25 showing prolonged immune cell activation
The FDA warns that it's very important that you may not stop taking Lamictal without first consulting a health care provider because doing this might cause serious problems including uncontrolled seizures. If you experienced Lamictal complication call Lamictal lawyer Timothy L. Miles about
Stevens Johnson Syndrome
Lamictal Stevens Johnson Syndrome is a hypersensitive reaction to a drug that attacks skin and mucous membranes. Lamictal Stevens Johnson Syndrome results in blisters and skin burns that cover as much as 30 percent of your body surface area.
A Lamictal rash like SJS can impact those in every age brackets and races, but it is more common in women than men with a small percentage.
Toxic Epidermal Necrolysis
Toxic Epidermal Necrolysis (TEN) is a more severe kind of Lamictal Stevens Johnson Syndrome. The top area it covers extends beyond 30 percent of the outer lining area.
While 50 percent of Stevens Johnson Syndrome cases are induced with a drug, up to 95 percent of TENs cases are precipitated by drug use. Drugs which can be known to induce TEN include Lamictal.
DRESS: Drug Reaction with Eosinophilia and Systemic Symptoms
Drug reaction with eosinophilia and systemic symptoms, or DRESS, is a serious adverse drug reaction which is characterized by a comprehensive skin rash plus association with visceral organ involvement, lymphadenopathy, eosinophilia, and atypical lymphocytosis.
Ask a Lamictal Lawyer in case a Lamictal Lawsuit Right for You?
A Lamictal rash diagnosis of one of many conditions detailed above is frightening enough for everyone affected. Treating conditions such as for example Lamictal Stevens Johnson Syndrome, TEN, DRESS or HLH will likely require hospitalization. What this means is high medical costs and time far from work.
If you believe your diagnosis was brought on by Lamictal, you might be eligible for compensation by filing a Lamictal lawsuit.
Contact a Lamictal Lawyer, Timothy L. Miles, today for a totally free case evaluation about a Lamictal Lawsuit.
For more details make sure you click on this link Lamictal rash.